We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » India Withdraws Internal Guideline for Setting Drug Price Controls
India Withdraws Internal Guideline for Setting Drug Price Controls
India’s drug pricing control bureau has abruptly withdrawn a guideline for setting prices for many branded-generic drugs, a move that could bolster companies’ case in a lawsuit against the government’s pricing policies.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor